GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (TSXV:VIV) » Definitions » Total Current Liabilities

Avivagen (TSXV:VIV) Total Current Liabilities : C$8.44 Mil (As of Jul. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Avivagen Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Avivagen's total current liabilities for the quarter that ended in Jul. 2023 was C$8.44


Avivagen Total Current Liabilities Historical Data

The historical data trend for Avivagen's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avivagen Total Current Liabilities Chart

Avivagen Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.01 1.30 2.35 6.01 2.10

Avivagen Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.91 2.10 2.28 7.30 8.44

Avivagen Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Avivagen's Total Current Liabilities for the fiscal year that ended in Oct. 2022 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=1.2+0.835
+Other Current Liabilities+Current Deferred Liabilities
=0.063+0
=2.10

Avivagen's Total Current Liabilities for the quarter that ended in Jul. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=1.552+6.138
+Other Current Liabilities+Current Deferred Liabilities
=0.064+0.682
=8.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Avivagen Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Avivagen's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Avivagen (TSXV:VIV) Business Description

Traded in Other Exchanges
Address
100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.

Avivagen (TSXV:VIV) Headlines

From GuruFocus

3Q23 Results: Telef�nica Brasil S.A.

By PRNewswire 10-31-2023

1Q20 Results: Telefônica Brasil S.A.

By PRNewswire PRNewswire 05-06-2020

3Q21 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 10-28-2021

2Q20 Results: Telefônica Brasil S.A.

By PRNewswire PRNewswire 07-29-2020

4Q21 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 02-23-2022

1Q21 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 05-12-2021

DORCHESTER WEALTH MANAGEMENT Co Buys 2, Sells 3 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-04-2022

4Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 02-15-2023